Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Pathology / 病理學科所
  4. Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features
 
  • Details

Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features

Journal
Modern Pathology
Journal Volume
27
Journal Issue
8
Pages
1163-1173
Date Issued
2014
Author(s)
JAU-YU LIAU  
JIA-HUEI TSAI  
RAY-HWANG YUAN  
Chang C.-N.
Lee H.-J.
YUNG-MING JENG  
DOI
10.1038/modpathol.2013.241
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905502877&doi=10.1038%2fmodpathol.2013.241&partnerID=40&md5=ccefa2951487681c46dd10d10eafd4a3
https://scholars.lib.ntu.edu.tw/handle/123456789/473337
Abstract
On the basis of morphological features, we subclassified 189 intrahepatic cholangiocarcinomas into two subtypes: bile duct and cholangiolar. The cholangiolar type is composed of cuboidal to low columnar tumor cells that contain scanty cytoplasm. The bile duct type is composed of tall columnar tumor cells arranged in a large glandular pattern. In this study, 77 (41%) tumors were classified as the cholangiolar type and 112 (59%) tumors were classified as the bile duct type. The cholangiolar-type intrahepatic cholangiocarcinoma was more frequently associated with viral hepatitis, whereas all but one intrahepatic cholangiocarcinoma associated with intrahepatic lithiasis were classified as the bile duct type. Biliary intraepithelial neoplasm or intraductal papillary neoplasm of the bile duct could be identified in 50 bile duct-type intrahepatic cholangiocarcinomas (45%), but in only 3 cholangiolar-type intrahepatic cholangiocarcinomas (4%). Cholangiolar-type intrahepatic cholangiocarcinomas frequently expressed N-cadherin, whereas bile duct intrahepatic cholangiocarcinomas were more likely to express S100P, Trefoil factor 1, and anterior gradient 2. KRAS is mutated in 23 of 98 (23%) bile duct-type intrahepatic cholangiocarcinomas and in only 1 of 76 (1%) cholangiolar-type intrahepatic cholangiocarcinomas. Cholangiolar-type intrahepatic cholangiocarcinomas had a higher frequency of IDH1 or 2 mutations than did the bile duct-type intrahepatic cholangiocarcinomas. The molecular features of the bile duct-type intrahepatic cholangiocarcinoma were similar to those of hilar cholangiocarcinoma. Patients with the cholangiolar-type intrahepatic cholangiocarcinoma had higher 5-year survival rates than those of patients with the bile duct-type intrahepatic cholangiocarcinoma. Our results indicated that intrahepatic cholangiocarcinoma was a heterogeneous tumor. Subclassification of intrahepatic cholangiocarcinomas based on cholangiocytic differentiation divides them into two groups with different etiologies, clinical manifestations, and molecular pathogeneses. ? 2014 USCAP, Inc..
SDGs

[SDGs]SDG3

Other Subjects
biological marker; intestinal trefoil factor; isocitrate dehydrogenase; isocitrate dehydrogenase 1; K ras protein; nerve cell adhesion molecule; protein S 100; protein S100P; unclassified drug; tumor marker; adult; aged; article; bile duct carcinoma; cancer surgery; female; gene mutation; human; human tissue; intraductal papillary mucinous tumor; major clinical study; male; molecular pathology; neoplasm; pathogenesis; priority journal; stone formation; survival rate; tumor classification; virus hepatitis; Bile Duct Neoplasms; chemistry; Cholangiocarcinoma; cholelithiasis; classification; comparative study; complication; genetic predisposition; genetics; intrahepatic bile duct; Kaplan Meier method; middle aged; mortality; mutation; nomenclature; pathology; phenotype; proportional hazards model; risk factor; time; treatment outcome; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholelithiasis; Female; Genetic Predisposition to Disease; Hepatitis, Viral, Human; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Phenotype; Proportional Hazards Models; Risk Factors; Terminology as Topic; Time Factors; Treatment Outcome; Tumor Markers, Biological
Publisher
Nature Publishing Group
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science